Insights · Product Strategy & Commercial Growth

The Cause and Effect of Protein

How the protein boom, GLP-1 and fiber are reshaping product innovation and growth.

From the GreenfieldTable insights desk · The nutrient changes. The consumer problem doesn't.

I've never met a consumer who wanted protein. I've met plenty who wanted to be less hungry at three o'clock. The food industry has spent years treating those as the same thing. I don't think they are.

Protein is having an unusually long moment. Most nutrition trends burn out within a few years. Protein keeps expanding into new categories, new dayparts and new consumer occasions.

To be fair, protein deserves its moment. A typical 150-pound adult needs somewhere between 55 and 110 grams a day, depending on age and activity level. That's not an insignificant amount, but it isn't hard to reach either. A couple of eggs at breakfast gets you roughly a dozen grams. A serving of Greek yogurt adds another 15 to 20. A chicken breast at lunch contributes 25 to 30 more.

Before the protein cereal, protein chips, protein desserts and protein coffee enter the picture, most people are already much closer to their target than the marketing suggests.

That's what fascinates me about the protein moment. Protein matters. But we've largely moved beyond solving a nutritional problem and into solving a marketing problem.

Protein is now doing the work once done by low-fat, whole grain, antioxidants, probiotics, keto and collagen. The nutrient changes. The need for a compelling consumer story stays constant.

Protein became commercially valuable because it helped solve a real consumer problem: satiety. The industry translated that into protein claims. Consumers translated it into not being hungry an hour later.

Learning to Follow Consequences

One of my daughters taught me that milk protein could show up in a child's ears long before the food industry figured out how to put protein in coffee.

It wasn't an insight I arrived at quickly. Before food entered the conversation, we spent years with specialists chasing what looked like unrelated problems: recurring congestion, fluid in her ears, hearing that came and went, and a rotating cast of explanations that never quite explained everything.

What stayed with me wasn't the milk protein itself. It was the realization that the source of a problem can live far away from where the symptom shows up.

Most people look at food through ingredients. I look at ingredients through their consequences.

That observation followed me into my work. Over time, it became a working dictionary built from flavor systems, product development, commercialization and growth strategy, along with technology implementations, operations and enough meals in enough places to start seeing patterns.

When I look at a product, I'm reading three things at once: the behavior it's trying to change, the complexity required to deliver it, and whether a consumer will decide it's worth repeating.

Years of building products, scaling systems and leading teams through launches have made me skeptical of novelty as a strategy. I've seen too many companies mistake interest for adoption. Consumers may try something because it's new, but repeat purchase is earned only when the innovation solves a meaningful problem.

I've watched companies spend years optimizing ingredients while consumers quietly optimized for outcomes.

GLP-1 Is a Formulation Story

That distinction gets more interesting viewed through GLP-1.

Most of the conversation has focused on how much less people are eating, and the numbers justify it. Cornell research tracking 150,000 households found grocery spending fell 5.3% within six months of a household member starting a GLP-1, with savory snacks down 10.1%. What interests me is how users describe the experience. Foods they once enjoyed suddenly feel too sweet, too rich, too heavy, or simply not worth finishing.

I don't see GLP-1 as an appetite story. I see it as a formulation story.

After years of working on flavor systems, that's the read I keep coming back to. Howard Moskowitz's work on the "bliss point" helped define how food companies optimize sweetness, saltiness, richness and overall palatability. Entire categories were built around finding that point.

GLP-1 changes the conditions under which consumers experience those products. Companies invested billions optimizing foods for a predictable sensory response. When foods that once tasted balanced suddenly feel like too much, the product is no longer delivering the experience it was designed to deliver.

That's why I think the industry is drawing the wrong conclusion. The immediate response has been to add protein, launch GLP-1 product lines or shrink portions. Those are easy levers to pull. What I see is a reformulation opportunity.

Consider a brand that responds to slowing category growth by launching a higher-protein version of an existing product. The launch may earn distribution, trial and a stronger nutrition story. But if repeat purchase weakens because the product is still too sweet, too rich or too heavy, the business has solved the wrong problem. The result is another SKU, another innovation cycle and another claim competing for attention. Meanwhile, the original product sits untouched.

Renting demand

Borrowing interest from a trend instead of earning it with the product. When the trend moves on, the demand goes with it.

The obvious objection is that GLP-1 users are still a minority, so why touch the core? Because they're no longer a small one. Numerator's tracking now puts a current user in 22% of American households, and a household shares one pantry. The research also shows something the line-extension strategy misses: about a third of users stop the medication, and their spending drifts back. A GLP-1 product line chases a customer who comes and goes. A better core product keeps the household either way.

If my team and I were at the bench, we wouldn't start by asking how much protein to add. We'd start by re-establishing the sensory target: testing lower sweetness curves, lower flavor intensity, different fat delivery systems, and texture and viscosity changes that support satiety, along with the role fiber can play in fullness, digestive comfort and regularity. The question would be whether the product delivers satisfaction sooner and more efficiently than it did before. And we'd prove it before betting the brand on it, with a regional test measured on repeat purchase rather than trial.

Many companies are still optimizing for yesterday's definition of satisfaction. The real opportunity isn't adding another functional ingredient. It's recognizing that the relationship between flavor, fullness and reward may be changing.

Where Fiber Goes Next

All of which makes fiber the obvious next move, and the obvious read of it misses the point. Roughly 90 to 95% of Americans already fall short on fiber. Constipation is among the most commonly reported side effects of GLP-1 medications. And a market that spent years adding protein to everything solved for feeling full without solving for feeling good afterward. If protein was the industry's attempt to monetize fullness, fiber will be its attempt to monetize feeling better after eating.

That's the consensus forecast, and it's probably right. But my bet isn't really on fiber.

Fiber is simply the next clue. The more interesting question isn't what ingredient comes next. It's what the success of the previous ingredient revealed.

So here's a call worth checking. Fiber will have its moment, and much of it is being built the way protein was: an isolated ingredient added to a familiar product. Chicory root, inulin, prebiotic fiber in a soda. It's the next round of renting demand. These fibers are FDA-recognized, and some do real work. But Washington has just put forward its first proposed federal definition of ultra-processed food, and HHS has said ingredient-based front-of-pack labels should follow. Whether or not the final rule names added fibers, scrutiny is moving from the nutrition panel to the ingredient list.

Within 18 months, fiber claims will shift from how many grams to where the fiber came from. Watch the packaging. The brands that built fiber from beans and whole grains will lead with the source. The ones that added it will be explaining their ingredient lists, and some will find themselves on both sides of the trend at once.

From the Bench to the P&L

I've spent enough time moving between R&D benches, commercialization plans and portfolio reviews to know that a small change in how consumers experience a product eventually shows up everywhere, from velocity to capital allocation. By the time it shows up in the numbers, the consumer has often been telling you the story for months.

If I'm right, the payoff isn't limited to the formulation. It cascades through the business: fewer resources chasing claim-led innovation, fewer SKU extensions built to support the next marketing cycle, stronger repeat purchase, clearer assortment decisions, and innovation dollars directed toward improving the core product rather than layering on new functionality.

That's a very different growth model. One depends on finding the next claim. The other depends on making the product better and letting the P&L follow.

Run this quarter

Pull repeat rates on your last three claim-led launches and compare them with the core product each one extended. If the extension decays faster, you were renting demand.

That's usually where my conversations with operators start.

Most people see protein and fiber as separate trends. I see a chain of consequences. Consumer behavior is usually the earliest signal, and financial performance is usually the last.

The work is connecting the two before everyone else does.

Atsuko Boyd is a strategy and operations executive who turns innovation into commercial growth across CPG, hospitality, and food and beverage. She writes GreenfieldTable Insights.